Pfizer News, Corporate filings and Earnings/Conference Calls

Name: Latest research reports of Pfizer Ltd. authored by ICICI Direct and published by - Trendlyne research reports.
Item: Pfizer Ltd.
Rating: 5
Author: ICICI Direct

Keep track of all breaking news and updates on Pfizer from all sources in a single place.

Pfizer Ltd.

10 Feb 2026

5037.40

-1.64%

Pfizer shares jump 11% on posting healthy Q3 show; PAT up 11% YoY, Rev 20%

Business Standard

In the December quarter, Pfizer reported an 11 per cent rise in consolidated net profit to 1,41.84 crore, compared to 127.6 crore a year ago

Pfizer Ltd. average weekly volume is high.

Pfizer Ltd.

10 Feb 2026

5037.40

-1.64%

Pfizer Ltd

Buy: Pfizer Ltd.

Recommendation Target

ICICI Direct

Q3FY26 - Strong Revenue growth and margins- Revenues grew ~20% to ~ 645 crore, driven by growth in power brands such as Mucaine (Antacid), Eliquis (CVS), among others. Brands such as Minipress XL (CVS), and Becosules (VMS) also registered moderate growth. On the other hand, there was a de-growth in other power brands such as Corex DX (cough syrup), Dolonex (pain management) and Prevnar 13 (pneumococcal vaccine). EBITDA grew 56% with a strong margin expansion of 824 bps YoY to 35.4%. GPM grew by 169 bps to 65.2%. PAT grew 11% with a...

Pfizer Ltd. is trading below its 150 day SMA of 5089.6

Pfizer Ltd.

09 Feb 2026

5037.40

-1.64%

Board Meeting

Pfizer Ltd - 500680 - Board Meeting Outcome for Outcome Of Board Meeting - Unaudited Financial …

BSE India

Pursuant to Regulations 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we submit herewith the Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2025, which were approved by the Board of Directors of the Company at their Meeting held today i.e., February 9, 2026, that commenced at 3.00 p.m. and concluded at 4.45 p.m.

pdf

Pfizer Ltd.

05 Feb 2026

5037.40

-1.64%

Company Update

Pfizer Ltd - 500680 - Newspaper Advertisement

BSE India

Newspaper Advertisement for re-lodgement of Transfer and Dematerialisation of Physical Securities.

pdf

Pfizer Ltd.

30 Jan 2026

5037.40

-1.64%

Board Meeting

Pfizer Ltd - 500680 - Board Meeting Intimation for Board Meeting To Consider And Approve The …

BSE India

Pfizer Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2026 ,inter alia, to consider and approve This is to inform that a meeting of the Board of Directors of the Company is scheduled to be held on Monday, February 9, 2026 inter alia, to consider, approve and take on record the Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2025.

pdf

Pfizer Ltd.

20 Jan 2026

5037.40

-1.64%

Company Update

Pfizer Ltd - 500680 - Announcement under Regulation 30 (LODR)-Change in Management

BSE India

Intimation regarding change in Senior Management

pdf

Pfizer Ltd.

09 Jan 2026

5037.40

-1.64%

Company Update

Pfizer Ltd - 500680 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Please find enclosed herewith the certificate confirming compliance with Regulation 74(5) of the SEBI (DP) Regulations, 2018, for the quarter ended December, 31, 2025.

pdf

Pfizer Ltd.

29 Dec 2025

5037.40

-1.64%

SAST

Pfizer Ltd - 500680 - Closure of Trading Window

BSE India

This is to inform you that the trading window for trading in shares of the Company shall remain closed from Wednesday, December 31, 2025 (close of business) till 48 hours after the financial results are made public.

pdf